Fingerprint
Dive into the research topics of 'A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
Hua Jay J. Cherng, Stefan K. Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu, Francesco Turturro, Fredrick Hagemeister, Alexander F.M. Craig, Charles W. Macaulay, Maria Alma Rodriguez, Hun Ju Lee, Timothy J. McDonnell, Christopher R. Flowers, Francisco Vega, Michael R. Green, Lei Feng, David M. Kurtz, Ash A. Alizadeh, R. Eric Davis
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations